STX buy signal a huge momentum breaks channel with force. we 75% of probability we will see a bullish trend after pull back
−40.44 MGBP
4.47 MGBP
536.45 M
About SHIELD THERAPEUTICS PLC ORD GBP0.015
Sector
CEO
Gregory Paul Madison
Headquarters
Gateshead Quays
Website
Employees (FY)
27
Founded
2015
ISIN
GB00BYV81293
FIGI
BBG009YWHXG4
Shield Therapeutics Plc is a commercial stage specialty pharmaceutical company, which engages in addressing iron deficiency with its lead product Accrufer. It operates the Feraccru and PT20 segments. The Feraccru segment refers to the development and commercialization of this product. The PT20 segment related to the development of its secondary asset. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Gateshead Quays, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of STX is 1.475 GBX — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange SHIELD THERAPEUTICS PLC ORD GBP0.015 stocks are traded under the ticker STX.
SHIELD THERAPEUTICS PLC ORD GBP0.015 is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
STX stock is 5.63% volatile and has beta coefficient of 1.40. Check out the list of the most volatile stocks — is SHIELD THERAPEUTICS PLC ORD GBP0.015 there?
One year price forecast for SHIELD THERAPEUTICS PLC ORD GBP0.015 has a max estimate of 0.020 GBX and a min estimate of 0.020 GBX.
Yes, you can track SHIELD THERAPEUTICS PLC ORD GBP0.015 financials in yearly and quarterly reports right on TradingView.
STX stock has fallen by 6.20% compared to the previous week, the month change is a 29.35% fall, over the last year SHIELD THERAPEUTICS PLC ORD GBP0.015 has showed a 77.77% decrease.
Today SHIELD THERAPEUTICS PLC ORD GBP0.015 has the market capitalization of 11.54 M, it has decreased by 15.00% over the last week.
No, STX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, STX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHIELD THERAPEUTICS PLC ORD GBP0.015 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 27.00 employees. See our rating of the largest employees — is SHIELD THERAPEUTICS PLC ORD GBP0.015 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHIELD THERAPEUTICS PLC ORD GBP0.015 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHIELD THERAPEUTICS PLC ORD GBP0.015 stock shows the sell signal. See more of SHIELD THERAPEUTICS PLC ORD GBP0.015 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SHIELD THERAPEUTICS PLC ORD GBP0.015 future price: according to them, STX price has a max estimate of 2.00 GBX and a min estimate of 2.00 GBX. Read a more detailed SHIELD THERAPEUTICS PLC ORD GBP0.015 forecast: see what analysts think of SHIELD THERAPEUTICS PLC ORD GBP0.015 and suggest that you do with its stocks.